Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Tetrazolyl oxime derivative, salt thereof, and plant disease control agent
Cylindrical lithium secondary battery comprising a contoured center pin
Electro-optical device, method of manufacturing the same, and electronic apparatus
Method and system for distributing ringback files
Knife grip
Negative active material for a rechargeable lithium battery, a method of preparing the same, and a rechargeable lithium battery comprising the same
Image forming apparatus
  Randomly Featured Patents
Range-finding method and apparatus
Method for reducing the content of spurious signals in the output signals of a mixer, and mixer for carrying out the method
Protection for spacecraft
Method for annealing domain wall displacement type magneto-optical disc and magneto-optical disc
Process for the preparation of aldehydes by hydroformylation of olefins
Method and apparatus for serving and displaying food
Method and apparatus for packaging flip chip bare die on printed circuit boards
Top-loading stapler
Imaging apparatus with three dimensional circuit board
(2-quinoxalinyloxy) phenoxypropanoic acids and related derivatives as anticancer agents